Clinical trial
A Double-Blind, Placebo-Controlled Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill Administered to Subjects With Alzheimer's Disease
NCT06597058 is registered in ClinicalTrials.gov with Noah Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill Administered to Subjects With Alzheimer's Disease
- Lead sponsor
- Noah Pharmaceuticals, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 16, 2024
- Completion date
- December 15, 2025
- Enrollment
- 121 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.